Association between cholesterol and liver injury risk in solid cancer patients treated with PD-1 inhibitors: evidence from two cohort studies

Abstract Background To assess the association between baseline serum lipids and the risk of severe hepatic immune-related adverse events (irAEs) in solid cancer patients treated with PD-1 inhibitors. Methods This retrospective study included a discovery cohort (N = 601) and an independent high-risk...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Jing Lei, Yi Wang, Zhiping Jin, Guoyou Qin, Tianshu Liu, Ningping Zhang, Minzhi Lv
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2026-02-01
Cyfres:	BMC Cancer
Pynciau:	Immune checkpoint inhibitor Hepatic immune-related adverse events Lipid metabolism Total cholesterol Low-density lipoprotein cholesterol.
Mynediad Ar-lein:	https://doi.org/10.1186/s12885-026-15801-0
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!